RGS22 and neoplasm: In another instance, G-protein signalling 22 (RGS22) functions as a tumour suppressive CTA to exhibit tumour progression by inhibiting tumour cell invasion and metastasis in liver cancer, pancreatic adenocarcinoma and epithelial cancers (78, 79).